Clinical trial reporting performance of thirty UK universities on ClinicalTrials.gov—evaluation of a new tracking tool for the US clinical trial registry
Abstract Clinical trial transparency forms the foundation of evidence-based medicine, and trial sponsors, especially publicly funded institutions such as universities, have an ethical and scientific responsibility to make the results of clinical trials publicly available in a timely fashion. We asse...
Main Authors: | Sarai Mirjam Keestra, Florence Rodgers, Daphne Lenz, Rhiannon Osborne, Till Bruckner, Sean Lee |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-06-01
|
Series: | Trials |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13063-021-05330-5 |
Similar Items
-
Updated analysis of pediatric clinical studies registered in ClinicalTrials.gov, 2008–2019
by: Yang Zhong, et al.
Published: (2021-04-01) -
Comprehensive Survey of Clinical Trials Registration for Melanoma Immunotherapy in the ClinicalTrials.gov
by: Yan-Bo Wang, et al.
Published: (2020-01-01) -
Clinical Trials for Artificial Intelligence in Cancer Diagnosis: A Cross-Sectional Study of Registered Trials in ClinicalTrials.gov
by: Jingsi Dong, et al.
Published: (2020-09-01) -
Some data quality issues at ClinicalTrials.gov
by: Neha Chaturvedi, et al.
Published: (2019-06-01) -
Registration of phase 3 crossover trials on ClinicalTrials.gov
by: Lijuan Zeng, et al.
Published: (2020-07-01)